3alpha,6beta-Dihydroxy-5alpha-androstan-17-one

cas: 152886-16-3 — zobacz wszystkie produkty o tym numerze CAS, także pod innymi nazwami

3alpha,6beta-Dihydroxy-5alpha-androstan-17-one (CAS 152886-16-3) to odczynnik chemiczny dostępny w ofercie Chemat. Dostępne opakowania: 100mg. Oferty producentów: TRC.

producentTRC
nr katalogowyTRC-D985550-100MG
cas152886-16-3
opakowanie100mg
Potrzebujesz dodatkowych informacji?

Zadaj nam pytanie o ten produkt — chętnie pomożemy.

Dostępne opakowania

producent opakowanie cena
TRC 100mg cena na żądanie

właściwości

czystośćNo data
czas dostawyDo potwierdzenia przez Chemat
Wzór strukturalny: {0} (CAS {1})

(3R,5S,6R,8R,9S,10R,13S,14S)-3,6-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one (CAS 152886-16-3) to związek chemiczny o wzorze sumarycznym C19H30O3 i masie molowej 306.4 g/mol. Nazwa systematyczna IUPAC: (3R,5S,6R,8R,9S,10R,13S,14S)-3,6-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one. InChIKey: ACXNWFRSEGWJGF-MLQQIXETSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H30O3
Masa molowa306.4 g/mol
Nazwa IUPAC(3R,5S,6R,8R,9S,10R,13S,14S)-3,6-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one
InChIKeyACXNWFRSEGWJGF-MLQQIXETSA-N
SMILESC[C@]12CC[C@H](C[C@@H]1[C@@H](C[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 3?,6?-Dihydroxy-5?-androstan-17-one, 6b-Hydroxyandrosterone, 3alpha,6beta-Dihydroxy-5alpha-androstan-17-one
Izomery (ten sam wzór sumaryczny)
dodecyl 2-hydroxybenzoate C19H30O3
dodecyl 4-hydroxybenzoate C19H30O3
ethyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate C19H30O3
(3R,5S,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(1S,3aS,3bR,5aR,9aR,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydroindeno[5,4-f]chromen-7-one C19H30O3
(4R,6R)-6-[2-[(1S,2S,4aR,6R,8aS)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]ethyl]-4-hydroxyoxan-2-one C19H30O3
(1S,3aS,3bR,5aS,9aR,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydroindeno[5,4-f]chromen-7-one C19H30O3
(3S,4S,5R,8R,9S,10R,13S,14S)-3,4-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one C19H30O3
(4aS,4bR,6aR,10aS,10bS,12aS)-8-hydroxy-10a,12a-dimethyl-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydronaphtho[2,1-f]chromen-2-one C19H30O3
(3R,5R,8R,9S,10S,13S,14S,16R)-3,16-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(3R,5R,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3